PAND - Pandion Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-0.2. This is a potential upside of $-0.2 (0%) from yesterday's end of day stock price of $0.

Pandion Therapeutics's activity chart (see below) currently has 1 price targets and 3 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 7 days.

Most recent stock forecast was given by GEOFFREY PORGES from LEERINK on 25-Feb-2021. First documented stock forecast 10-Aug-2020.

Best performing analysts who are covering PAND - Pandion Therapeutics:

Geoffrey Porges

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$60

$-0.05 (-0.08%)

4 years 7 months 29 days ago
(25-Feb-2021)

1/1 (100%)

$-0.2 (-0.33%)

7

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PAND (Pandion Therapeutics) average time for price targets to be met?

On average it took 7 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on PAND (Pandion Therapeutics) with a proven track record?

GEOFFREY PORGES

Which analyst has the most public recommendations on PAND (Pandion Therapeutics)?

Geoffrey Porges has 4 price targets and 6 ratings on PAND

Which analyst is the currently most bullish on PAND (Pandion Therapeutics)?

Geoffrey Porges with highest potential upside - $-0.05

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?